Search research articles
Contact Us
Filters
Showing results (181-190 of 195) with videos related to
Page
of 20
Sort By:
Journal of Thoracic Imaging
|
July 4, 2019
Computed Tomography-based Body Composition Analysis and Its Role in Lung Cancer Care
Amelie S Troschel, Fabian M Troschel, Till D Best, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 30, 2020
Relationship of IGF-1 and IGF-Binding Proteins to Disease Severity and Glycemia in Nonalcoholic Fatty Liver Disease
Takara L Stanley, Lindsay T Fourman, Isabel Zheng, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 23, 2015
Metabolic Effects of Long-Term Reduction in Free Fatty Acids With Acipimox in Obesity: A Randomized Trial
Hideo Makimura, Takara L Stanley, Caroline Suresh, et al.
Open Forum Infectious Diseases
|
August 10, 2023
Visceral Adiposity Index as a Measure of Cardiovascular Disease in Persons With Human Immunodeficiency Virus
Teressa S Thomas, Carolyn Dunderdale, Michael T Lu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 10, 2020
Clinical Predictors of Liver Fibrosis Presence and Progression in Human Immunodeficiency Virus-Associated Nonalcoholic Fatty Liver Disease
Lindsay T Fourman, Takara L Stanley, Isabel Zheng, et al.
Scientific Reports
|
May 19, 2021
Delineating tesamorelin response pathways in HIV-associated NAFLD using a targeted proteomic and transcriptomic approach
Lindsay T Fourman, Takara L Stanley, James M Billingsley, et al.
Contemporary Clinical Trials
|
September 10, 2022
A randomized, double-blind, placebo-controlled clinical trial of 8-week intranasal oxytocin administration in adults with obesity: Rationale, study design, and methods
Marie-Louis Wronski, Franziska Plessow, Liya Kerem, et al.
European Journal of Endocrinology
|
January 26, 2012
Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial
Miriam A Bredella, Eleanor Lin, Danielle J Brick, et al.
Contemporary Clinical Trials
|
March 24, 2024
Corrigendum to "A randomized, double-blind, placebo-controlled clinical trial of 8-week intranasal oxytocin administration in adults with obesity: Rationale, study design, and methods" [Contemporary Clinical Trials 122 (2022) 1-11/106909]
Marie-Louis Wronski, Franziska Plessow, Liya Kerem, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 17, 2018
Randomized, Placebo-Controlled Trial to Evaluate Effects of Eplerenone on Metabolic and Inflammatory Indices in HIV
Suman Srinivasa, Kathleen V Fitch, Kimberly Wong, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 195) with videos related to
Sort By:
Page
of 20
Journal of Thoracic Imaging
|
July 4, 2019
Computed Tomography-based Body Composition Analysis and Its Role in Lung Cancer Care
Amelie S Troschel, Fabian M Troschel, Till D Best, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 30, 2020
Relationship of IGF-1 and IGF-Binding Proteins to Disease Severity and Glycemia in Nonalcoholic Fatty Liver Disease
Takara L Stanley, Lindsay T Fourman, Isabel Zheng, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 23, 2015
Metabolic Effects of Long-Term Reduction in Free Fatty Acids With Acipimox in Obesity: A Randomized Trial
Hideo Makimura, Takara L Stanley, Caroline Suresh, et al.
Open Forum Infectious Diseases
|
August 10, 2023
Visceral Adiposity Index as a Measure of Cardiovascular Disease in Persons With Human Immunodeficiency Virus
Teressa S Thomas, Carolyn Dunderdale, Michael T Lu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 10, 2020
Clinical Predictors of Liver Fibrosis Presence and Progression in Human Immunodeficiency Virus-Associated Nonalcoholic Fatty Liver Disease
Lindsay T Fourman, Takara L Stanley, Isabel Zheng, et al.
Scientific Reports
|
May 19, 2021
Delineating tesamorelin response pathways in HIV-associated NAFLD using a targeted proteomic and transcriptomic approach
Lindsay T Fourman, Takara L Stanley, James M Billingsley, et al.
Contemporary Clinical Trials
|
September 10, 2022
A randomized, double-blind, placebo-controlled clinical trial of 8-week intranasal oxytocin administration in adults with obesity: Rationale, study design, and methods
Marie-Louis Wronski, Franziska Plessow, Liya Kerem, et al.
European Journal of Endocrinology
|
January 26, 2012
Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial
Miriam A Bredella, Eleanor Lin, Danielle J Brick, et al.
Contemporary Clinical Trials
|
March 24, 2024
Corrigendum to "A randomized, double-blind, placebo-controlled clinical trial of 8-week intranasal oxytocin administration in adults with obesity: Rationale, study design, and methods" [Contemporary Clinical Trials 122 (2022) 1-11/106909]
Marie-Louis Wronski, Franziska Plessow, Liya Kerem, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 17, 2018
Randomized, Placebo-Controlled Trial to Evaluate Effects of Eplerenone on Metabolic and Inflammatory Indices in HIV
Suman Srinivasa, Kathleen V Fitch, Kimberly Wong, et al.
Page
of 20